539 related articles for article (PubMed ID: 29848096)
1. Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer.
Anari F; Ramamurthy C; Zibelman M
Future Oncol; 2018 Jun; 14(14):1409-1421. PubMed ID: 29848096
[TBL] [Abstract][Full Text] [Related]
2. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
3. Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers.
Mushtaq MU; Papadas A; Pagenkopf A; Flietner E; Morrow Z; Chaudhary SG; Asimakopoulos F
J Immunother Cancer; 2018 Jul; 6(1):65. PubMed ID: 29970158
[TBL] [Abstract][Full Text] [Related]
4. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
5. Rationale for anti-CD137 cancer immunotherapy.
Makkouk A; Chester C; Kohrt HE
Eur J Cancer; 2016 Feb; 54():112-119. PubMed ID: 26751393
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor Microenvironment.
Cui Y; Guo G
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869779
[TBL] [Abstract][Full Text] [Related]
7. Stromal contributions to the carcinogenic process.
Spaw M; Anant S; Thomas SM
Mol Carcinog; 2017 Apr; 56(4):1199-1213. PubMed ID: 27787930
[TBL] [Abstract][Full Text] [Related]
8. Toward Normalization of the Tumor Microenvironment for Cancer Therapy.
Zheng J; Gao P
Integr Cancer Ther; 2019; 18():1534735419862352. PubMed ID: 31282197
[TBL] [Abstract][Full Text] [Related]
9. The tumor microenvironment: part 1.
Leibovici J; Itzhaki O; Huszar M; Sinai J
Immunotherapy; 2011 Nov; 3(11):1367-84. PubMed ID: 22053887
[TBL] [Abstract][Full Text] [Related]
10. Targeting the tumor microenvironment: from understanding pathways to effective clinical trials.
Fang H; Declerck YA
Cancer Res; 2013 Aug; 73(16):4965-77. PubMed ID: 23913938
[TBL] [Abstract][Full Text] [Related]
11. Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies.
Liu Y; Guo J; Huang L
Theranostics; 2020; 10(7):3099-3117. PubMed ID: 32194857
[TBL] [Abstract][Full Text] [Related]
12. Beyond the tumour microenvironment.
Laplane L; Duluc D; Bikfalvi A; Larmonier N; Pradeu T
Int J Cancer; 2019 Nov; 145(10):2611-2618. PubMed ID: 30989643
[TBL] [Abstract][Full Text] [Related]
13. Targeting tumor microenvironment in ovarian cancer: Premise and promise.
Jiang Y; Wang C; Zhou S
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188361. PubMed ID: 32234508
[TBL] [Abstract][Full Text] [Related]
14. Targeting the tumor microenvironment by immunotherapy: part 2.
Leibovici J; Itzhaki O; Huszar M; Sinai J
Immunotherapy; 2011 Nov; 3(11):1385-408. PubMed ID: 22053888
[TBL] [Abstract][Full Text] [Related]
15. Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention.
El-Nikhely N; Larzabal L; Seeger W; Calvo A; Savai R
Expert Opin Investig Drugs; 2012 Aug; 21(8):1107-22. PubMed ID: 22667993
[TBL] [Abstract][Full Text] [Related]
16. Targeting the microenvironment in solid tumors.
Belli C; Trapani D; Viale G; D'Amico P; Duso BA; Della Vigna P; Orsi F; Curigliano G
Cancer Treat Rev; 2018 Apr; 65():22-32. PubMed ID: 29502037
[TBL] [Abstract][Full Text] [Related]
17. Interventions that induce modifications in the tumor microenvironment.
Bernhard EJ
Cancer Radiother; 2011 Aug; 15(5):376-82. PubMed ID: 21571567
[TBL] [Abstract][Full Text] [Related]
18. Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors.
Lu S; Zhang J; Liu D; Li G; Staveley-O'Carroll KF; Li Z; Wu JD
Clin Cancer Res; 2015 Nov; 21(21):4819-30. PubMed ID: 26106076
[TBL] [Abstract][Full Text] [Related]
19. Immune control in hepatocellular carcinoma development and progression: role of stromal cells.
Sprinzl MF; Galle PR
Semin Liver Dis; 2014 Nov; 34(4):376-88. PubMed ID: 25369300
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
